NCCN 2021 Virtual Congress: Hematologic Malignancies™
Live Virtual Program was held Thursday, October 14, 2021 – Saturday, October 16, 2021

Save the Date! The NCCN 2022 Annual Congress: Hematologic Malignancies™ will take place Friday, October 14, 2022 – Saturday, October 15, 2022, in New York, New York.

Co-chairs Ranjana H. Advani, MD, Stanford Cancer Institute, and Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center, led expert discussions on the latest advances, updates to the NCCN Guidelines^®, and unique and challenging patient cases.

View Recorded Presentations

Topics Include:

• Updates in the Management of Newly Diagnosed Acute Myeloid Leukemia
• Debate – Response Milestones that Matter in Chronic Myeloid Leukemia: MMR vs. CCyR
• Patient Case Studies and Panel Discussion: Leukemias
• Mutational Landscape in Myeloproliferative Neoplasms: Implications on Prognosis and Clinical Management
• Recommendations for Managing Adults with Histiocytic Neoplasms: New NCCN Guidelines
• Newly Diagnosed Multiple Myeloma: How Many Drugs are Enough?
• Maneuvering the Complex Web of Treatment Options for Relapsed/Refractory Multiple Myeloma
• Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms
• Optimizing Treatment Approaches for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
• Minimal Residual Disease Assessment in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Is it Ready for Routine Clinical Practice?
• Updates in the Management of Early-Stage Diffuse Large B-Cell Lymphoma
• Diffuse Large B-Cell Lymphoma: Optimizing Therapy for Relapsed/Refractory Disease
• Patient Case Studies and Panel Discussion: Lymphomas
• Mantle Cell Lymphoma: Updates in the Management of Relapsed/Refractory Disease
• Optimizing First-Line Therapy for Advanced Stage Classic Hodgkin Lymphoma

View Recorded Presentations

Accreditation

This program is approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals.